Katy Gallop

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Ejection Fraction

Mild Cognitive Impairment

Top Venues

Journal of comparative effectiveness research

Neurodegenerative disease management

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Daniel Aggio, Katy Gallop, Villum Wittrup-Jensen, Soulmaz Fazeli Farsani, Andrew J Lloyd
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment. Journal of comparative effectiveness research 13 (2) (2024)
Katy Gallop, Ngan Pham, Grant Maclaine, Emma Saunders, Bonnie Black, Sarah Acaster
Exploring the impact of caring for an individual with neurogenic orthostatic hypotension: a qualitative study. Neurodegenerative disease management (2023)
Katy Gallop, Sarah Acaster, Jane de Vries, Richard Browne, Robert Ryan, Sarah Baker, George Du Toit
Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers. Patient preference and adherence 16 (2022)
Marina Tsoumani, Lynne Regent, Amena Warner, Katy Gallop, Ram Patel, Robert Ryan, Andrea Vereda, Sarah Acaster, Audrey DunnGalvin, Aideen M Byrne
Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland. PloS one 17 (2) (2022)
Katy Gallop, Ngan Pham, Grant Maclaine, Emma Saunders, Bonnie Black, Lena Hubig, Sarah Acaster
Health related quality-of-life and burden for caregivers of individuals with neurogenic orthostatic hypotension. Neurodegenerative disease management (2022)
Trevor Thompson, Fiona Whiter, Katy Gallop, Nicola Veronese, Marco Solmi, Paul Newton, Brendon Stubbs
NMDA receptor antagonists and pain relief: A meta-analysis of experimental trials. Neurology 92 (14) (2019)